Back
Fossil Group Vs. Akero Therapeutics Industry Stock Comparison
Sell
37
FOSL
Fossil Group
Last Price:
0.82
Seasonality Move:
5.54%
Sell
28
AKRO
Akero Therapeutics
Last Price:
20.24
Seasonality Move:
16.15%
Sell
37
Fossil Group (FOSL)
is a Sell
Is Fossil Group a Buy, Sell or Hold?
- The current Fossil Group [FOSL] share price is $0.84. The Score for FOSL is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- FOSL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $21.00. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FOSL Stock Price Chart
What is Fossil Group's stock price today?
-
The Fossil Group share price today is $0.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOSL is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $21.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
FOSL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 41.49 | Sell |
Chaikin Money Flow: | -80898 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.84 - 1) | Sell |
Bollinger Bands (100): | (0.92 - 1.34) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.18 | Sell |
Relative Strength Index (14 RSI): | 35.31 | Sell |
Chaikin Money Flow: | 33831 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.5 - 24.76) | Sell |
Bollinger Bands (100): | (19.91 - 26.11) | Sell |
FOSL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.83 | Buy |
20-day SMA: | 0.92 | Sell |
50-day SMA: | 0.96 | Sell |
200-day SMA: | 1.56 | Sell |
8-day EMA: | 0.85 | Sell |
20-day EMA: | 0.89 | Sell |
50-day EMA: | 0.98 | Sell |
200-day EMA: | 1.66 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.3 | Sell |
20-day SMA: | 22.6 | Sell |
50-day SMA: | 24.68 | Sell |
200-day SMA: | 29.2 | Sell |
8-day EMA: | 21.33 | Sell |
20-day EMA: | 22.52 | Sell |
50-day EMA: | 23.52 | Sell |
200-day EMA: | 27.68 | Sell |
Fossil Group Earnings Growth & FOSL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
Fossil Group Technical Analysis
Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |